MSD Animal Health’s $1.3 billion acquisition propels it into the shrimp industry

The Elanco deal will "significantly increase our presence and our focus in aquaculture," MSD Animal Health vice president of global business development tells IntraFish.

"It’s very clear we’re willing to invest [in aquaculture]," said Jim McIntyre, vice president of global business development at MSD Animal Health.
"It’s very clear we’re willing to invest [in aquaculture]," said Jim McIntyre, vice president of global business development at MSD Animal Health.Photo: LinkedIn
Published 29 July 2024, 12:55Updated 29 July 2024, 12:56
MSD Animal HealthVaccinesPancreas Disease (PD)Sea liceDiseases